Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001055726-24-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-28 | 2024-02-26 | INO | Shea Jacqueline Elizabeth | CEO, Dir | F - Tax | $8.16 | -3,728 | 20.5K | -15% | -$30.4K |
| DM | 2024-02-28 | 2024-02-26 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | — | +7,731 | 23.4K | +49% | — |
| DM | 2024-02-28 | 2024-02-26 | INO | Shea Jacqueline Elizabeth | CEO, Dir | M - OptEx | $0.00 | -7,731 | 5,852 | -57% | $0 |
| DM | 2024-02-28 | 2024-02-28 | INO | Shea Jacqueline Elizabeth | CEO, Dir | A - Grant | $0.00 | +125.6K | 55.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-26 | F | D | 872 | $8.16 | 17,515 | D | — | — | (F3) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein. |
| 2 | Common | Common Stock | 2024-02-26 | M | A | 1,878 | — | 18,387 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. |
| 3 | Common | Common Stock | 2024-02-26 | M | A | 5,853 | — | 23,368 | D | — | — | (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 4 | Common | Common Stock | 2024-02-26 | F | D | 2,856 | $8.16 | 20,512 | D | — | — | (F5) The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein. |
| 5 | Derivative | Restricted Stock Unit | 2024-02-26 | M | D | 1,878 | $0.00 | 0 | D | — · — to — | 1,878 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both. |
| 6 | Derivative | Restricted Stock Unit | 2024-02-26 | M | D | 5,853 | $0.00 | 5,852 | D | — · — to — | 5,853 Common Stock | (F2) Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024. (F4) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |
| 7 | Derivative | Common Stock Option | 2024-02-28 | A | A | 69,733 | $0.00 | 69,733 | D | $8.46 · 2024-02-28 to 2034-02-28 | 69,733 Common Stock | (F6) The vesting schedule for the 69,733 options is as follows: 17,434 shares vested on February 28, 2024; 17,433 shares will vest on February 28, 2025; 17,433 shares will vest on February 28, 2026; and 17,433 shares will vest on February 28, 2027. |
| 8 | Derivative | Restricted Stock Unit | 2024-02-28 | A | A | 55,895 | $0.00 | 55,895 | D | — · — to — | 55,895 Common Stock | (F7) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 55,895 restricted stock units is as follows: 18,632 shares will vest on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. |